Sangamo Therapeutics delisted
- Form 25-NSE filed on 2026-10-07
- Delisted effective 2026-10-16
- Nasdaq determined non-compliance with Listing Rule 5550(a)(2)
Nasdaq Stock Market LLC, filed by
Every EDGAR filing for SANGAMO THERAPEUTICS, INC (SGMO), newest first, with AI summaries and stories.
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
Nasdaq Stock Market LLC, filed by
Ownership stake disclosure by ARMISTICE CAPITAL, LLC (amended)
ARMISTICE CAPITAL, LLC, filed by
Nikunj Jain, insider filing for SGMO
Nikunj Jain, reporting
Ownership stake disclosure by ARMISTICE CAPITAL, LLC
ARMISTICE CAPITAL, LLC, filed by
Gregory D Davis, insider filing for SGMO
Gregory D Davis, reporting
Gregory D Davis, planned sale of SGMO shares
Gregory D Davis, reporting
Nathalie Dubois-Stringfellow, planned sale of SGMO shares
Nathalie Dubois-Stringfellow, reporting
Sandy Macrae, insider filing for SGMO
Sandy Macrae, reporting
Scott B. Willoughby, insider filing for SGMO
Scott B. Willoughby, reporting
Nikunj Jain, insider filing for SGMO
Nikunj Jain, reporting
Scott B. Willoughby, insider filing for SGMO
Scott B. Willoughby, reporting